Seeking Alpha

BlackbirdAnalytics

 
(In beta) Send Us Feedback»
Title Symbol Long/
Short
Date of
publication
3m from
publication
6m from
publication
1y from
publication
StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company STEM Long
5/2/2013
1.1%
-24.4%
-29.0%
Trading Athersys: Risks And Rewards ATHX Short
4/19/2013
-21.5%
-11.5%
36.5%
OncoGenex: A Cancer Biotech Worth Betting On OGXI Long
4/11/2013
-9.3%
-16.9%
-8.3%
A Candid Conversation With Athersys CEO Gil Van Bokkelen ATHX Long
1/31/2013
37.9%
-5.0%
139.1%
Athersys: A Significantly Undervalued Stem Cell Company Approaching Key Catalysts ATHX Long
1/29/2013
56.4%
10.0%
171.4%
Trading Allon Therapeutics: Risks And Rewards NPCUF Long
11/12/2012
-
-
-
Straight Talk From Allon Therapeutics CEO Gordon McCauley NPCUF Long
10/3/2012
-
-
-